Aeolus Announces First Quarter Fiscal Year 2016 Financial Results
MISSION VIEJO, CA--(Marketwired - February 16, 2016) - Aeolus Pharmaceuticals, Inc. (OTCQB: AOLS), a biotechnology company developing compounds to protect against fibrosis, inflammation, nerve damage and infection announced today financial results for the …